Watson Pharma Private Limited
FDA inspection history in Verna, India, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at Verna, India.
Cited most
Across all Watson Pharma Private Limited observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.192Production record review1
- 21 CFR 211.42Design and construction features1
- 21 CFR 314.81Other postmarketing reports1
The complete Watson Pharma Private Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Verna, India
One Form 483 · 2025 · 3 observations
Latest: Form 483, May 20, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-05-20 | 483 Form 483 | Verna, India | 3 | $99 |
Investigators on these documents
FEI number 3005719315 · most recent document May 20, 2025
About Watson Pharma Private Limited
How many FDA Form 483s has Watson Pharma Private Limited received?
FDA Intel has 1 Form 483 on file for Watson Pharma Private Limited; the most recent is dated May 20, 2025.
When was Watson Pharma Private Limited last inspected by FDA?
The most recent FDA inspection document on file for Watson Pharma Private Limited is a Form 483 dated May 20, 2025, for the site in Verna, India.
What did FDA cite at Watson Pharma Private Limited?
The regulations cited most in the observations on file for Watson Pharma Private Limited are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.42 (Design and construction features), 1 time.